The replenished ATM capacity ($5.06M) is a material dilutive risk for a $6M market cap stock. Expect continuous downward pressure as Wainwright sells into the market. Combined with the separate S-3 resale registration covering up to 5.3M shares from pre-funded warrants and convertible preferred, the total potential share overhang is severe. Short-term bearish; avoid longs until ATM activity is exhausted and share count stabilizes.
How the stock moved after the report
BEARISH VIEWSTOCK ABOVE ENTRY AT T+60- T+0 · Jun 17 $0.5500entry
- T+1 · 5mo ago −5.47%α −6.25% · $0.5199
- T+5 · 5mo ago −24.27%α −23.23% · $0.4165
- T+20 · 4mo ago −62.36%α −63.68% · $0.2070
- T+60 · 2mo ago +236.36%α +233.22% · $1.85
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
BiomX filed a prospectus supplement to update its ATM offering capacity, authorizing up to $5,061,000 in common stock sales through H.C. Wainwright. This updates prior ATM programs under the same S-3 shelf. The filing is a routine administrative update to replenish offering capacity under the shelf's I.B.6 limitations and does not represent a new primary offering. Given the micro-cap ($6M market cap) and the dilutive overhang, the incremental capacity is notable for the stock's float.
Key Facts
- Up to $5,061,000 of common stock may be sold via ATM through H.C. Wainwright (replaces prior ATM capacity).
- Previously sold $1,376,214 under prior supplements on the same S-3 shelf.
- Outstanding shares: 11,797,449 as of June 16, 2026. Stock closed at $0.555/shr on June 15, 2026.
- Market cap ~$6M; the new ATM capacity represents ~84% of current market cap (at $0.555/shr).
- Non-affiliate public float valued at $19.25M based on $1.84 reference price from April 17, 2026.
- 12-month prior I.B.6 sales total $1,355,841. New limit of $5,061,000 resets the available capacity.
- The shelf also covers a separate resale registration (S-3 filed Feb 2026) for up to 5,310,933 shares from convertible preferred and warrants, creating additional potential dilution.
Financial Impact
Up to $5,061,000 in new ATM capacity, equivalent to roughly 84% of current market cap at the June 15 closing price of $0.555/shr. Overhang is significant for a micro-cap issuer.
Risk Factors
- Massive potential dilution relative to current float, $5.06M ATM plus 5.3M additional shares from the S-3 resale registration.
- ATM at-the-market sales by H.C. Wainwright likely to pressure price near the $0.555 level or lower.
- Micro-cap with weak institutional base (top holder Morgan Stanley at ~$72K) has limited absorption capacity.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 424B5 Filing (Primary) | 0001213900-26-069312 |
| Document: 0001213900-26-069312-index-headers.html | 0001213900-26-069312 |
| Document: 0001213900-26-069312-index.html | 0001213900-26-069312 |
| Document: 0001213900-26-069312.txt | 0001213900-26-069312 |
Track record
22 reports on PHGE
7 of 11 bullish or bearish reports moved the stock their way by T+1. Best: +43.24% at T+20 after the Jun 29, 2026 report. 7 of 11 went positive at some point.
Filters
- Oct 7, 20265w ago 8-K Neutral 4/10 Entry $0.3092 to $0.2915 ▼ −5.72% −5.30% vs SPY
- Oct 7, 20265w ago DEF 14A Bearish 6/10 Entry $0.3092 to $0.2915 ▲ +5.72% +5.30% vs SPY
- Sep 1, 202610w ago 8-K Neutral 3/10 Entry $0.1425 to $0.1421 ▼ −0.28% −1.33% vs SPY
- Aug 28, 202611w ago 8-K Neutral 4/10 Entry $0.1371 to $0.1430 ▲ +4.30% +4.99% vs SPY
- Aug 5, 202614w ago Press Release Bearish 5/10 Entry $0.1800 to $0.1598 ▲ +11.22% +11.06% vs SPY
- Jul 28, 202615w ago 8-K Bearish 8/10 Entry $0.1834 to $0.1830 ▲ +0.22% −1.32% vs SPY
- Jul 28, 202615w ago Press Release Bearish 7/10 Entry $0.1834 to $0.1830 ▲ +0.22% −1.32% vs SPY
- Jul 27, 202616w ago 424B5 Bearish 7/10 Entry $0.1834 to $0.1830 ▲ +0.22% −1.32% vs SPY
- Jul 8, 202618w ago Press Release Neutral 4/10 Entry $0.2758 to $0.2800 ▲ +1.52% +0.68% vs SPY
- Jul 2, 202619w ago 8-K Bearish 6/10 Entry $0.3190 to $0.3020 ▲ +5.33% +6.20% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers